Related Experiment Video
Updated: Feb 21, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Non-cancer mortality among people diagnosed with cancer (Australia)
Peter D Baade1, Lin Fritschi, Elizabeth G Eakin
1Epidemiology Unit, Viertel Centre for Research in Cancer Control, Queensland Cancer Fund, Spring Hill QLD, Brisbane, Australia. pbaade@qldcancer.com.au
Objective:
To investigate whether people diagnosed with cancer have an increased risk of death from non-cancer causes compared to the general population.
Methods:
The non-cancer mortality of people diagnosed with cancer in Queensland (Australia) between 1982 and 2002 who had not died before 1 January 1993 was compared to the mortality of the total Queensland population, matching by age group and sex, and reporting by standardised mortality ratios.
Results:
Compared to the non-cancer mortality in the general population, cancer patients (all cancers combined) were nearly 50% more likely to die of non-cancer causes (SMR = 149.9, 95% CI = [147-153]). This varied by cancer site. Overall melanoma patients had significantly lower non-cancer mortality, female breast cancer patients had similar non-cancer mortality to the general population, while increased non-cancer mortality risks were observed for people diagnosed with cervical cancer, colorectal cancer, prostate cancer, non-Hodgkin lymphoma and lung cancer.
Conclusions:
Although cancer-specific death rates underestimate the mortality directly associated with a diagnosis of cancer, quantifying the degree of underestimation is difficult due to various competing explanations. There remains an important role for future research in understanding the causes of morbidity among cancer survivors, particularly those looking at both co-morbid illnesses and reductions in quality of life.
Related Concept Videos
Cancer Survival Analysis
Cancer Prevention
Some...
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Psychoneuroimmunology: Diabetes and Cancer
Comparing the Survival Analysis of Two or More Groups

